XSD In The Semiconductor Boom, But Not The Choice I Prefer. Here's Why

The article argues that State Street's SPDR S&P Semiconductor ETF (XSD) uses an equal-weight methodology that materially underweights mega-cap names such as NVDA and AVGO in favor of mid- and small-cap semiconductor stocks. It is primarily a critique of portfolio construction and sector exposure, not a corporate event or earnings-driven catalyst. The piece suggests the ETF's structure diverges from the industry's concentration in a few dominant companies with strong moats.

Analysis

The key second-order effect is not just index construction drift, but a valuation and flow mismatch between “broad semis” wrappers and where the sector’s economic surplus is actually being captured. Equal-weight exposure forces capital into lower-quality, more cyclically exposed names that can look optically cheap on near-term earnings, while under-allocating to the few franchises that own the most durable pricing power, AI attach points, and ecosystem control. That setup can create persistent underperformance for equal-weight products in risk-on tape, especially when passive and thematic flows are chasing semiconductor beta rather than sector fundamentals.

For NVDA and AVGO, the near-term issue is less about business fundamentals and more about marginal buyer behavior. If investors want semis, the natural reflex is to buy the largest liquid leaders, so any structure that systematically suppresses their weights can become a source of relative demand for direct single-name ownership versus ETF wrappers. Over 1-3 months, this can support a premium for the megacaps versus the basket; over 12-24 months, it can widen if AI capex remains concentrated and the market keeps rewarding operating leverage and moat durability over breadth.

The contrarian view is that the market may be overestimating how linear the “few winners dominate” narrative will remain. If AI spend broadens into networking, power, analog, and specialty memory, equal-weight semis could catch up quickly as the under-owned mid-caps re-rate on earnings inflections. The main reversal catalyst is a shift from capex concentration to diffusion: if hyperscaler spending pauses or digestion lasts longer than expected, the mega-cap leadership premium can compress while the rest of the group gets a cyclical bounce.

Key Decisions for Investors

• Long NVDA / short XSD for 1-3 months as a relative-value expression of moat concentration vs forced equal-weight dilution; target is outperformance if AI leadership remains narrow, but cut quickly if the breadth trade starts to work.
• Long AVGO / short XSD on any pullback in the next 2-4 weeks; this is the cleaner quality-vs-basket trade because AVGO captures both AI infrastructure and resilient cash-flow compounder characteristics.
• If looking for cleaner sector beta, avoid using equal-weight semis as the core vehicle; prefer a concentrated basket of NVDA + AVGO with a smaller satellite in higher-beta suppliers, to reduce exposure to value traps in the mid-cap cohort.
• For options, buy 3-6 month call spreads on NVDA rather than outright shares if you want convex exposure to continued leadership; the thesis breaks if capex sentiment de-risks, but downside is defined.